Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2 Visceral Pain 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neuralgia 1 Neoplasms 1 Lymphoma 1 Leiomyoma 1 Earache 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Gemcitabine 100 130-nm albumin-bound paclitaxel 34 Oxaliplatin 28 Capecitabine 27 Fluorouracil 25 Albumin-Bound Paclitaxel 23 Leucovorin 19 Irinotecan 18 Erlotinib Hydrochloride 14 Cyclophosphamide 12 Radiosurgery 11 pembrolizumab 10 Radiotherapy 10 Nivolumab 10 Bevacizumab 10 Surgical Procedures, Operative 9 avelumab 7 Docetaxel 7 Taxes 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Specimen Handling 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 trametinib 4 spartalizumab 4 fludarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × Pregabalin × Clear all

NCT01768988 2017-10-06

PANPAIN/1

Parc de Salut Mar

Phase 4 Terminated

Gastrointestinal

Pancreatic Neoplasms, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡